Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 Jun 2024
Historique:
received: 20 01 2024
accepted: 28 05 2024
medline: 12 6 2024
pubmed: 12 6 2024
entrez: 11 6 2024
Statut: epublish

Résumé

Missions into Deep Space are planned this decade. Yet the health consequences of exposure to microgravity and galactic cosmic radiation (GCR) over years-long missions on indispensable visceral organs such as the kidney are largely unexplored. We performed biomolecular (epigenomic, transcriptomic, proteomic, epiproteomic, metabolomic, metagenomic), clinical chemistry (electrolytes, endocrinology, biochemistry) and morphometry (histology, 3D imaging, miRNA-ISH, tissue weights) analyses using samples and datasets available from 11 spaceflight-exposed mouse and 5 human, 1 simulated microgravity rat and 4 simulated GCR-exposed mouse missions. We found that spaceflight induces: 1) renal transporter dephosphorylation which may indicate astronauts' increased risk of nephrolithiasis is in part a primary renal phenomenon rather than solely a secondary consequence of bone loss; 2) remodelling of the nephron that results in expansion of distal convoluted tubule size but loss of overall tubule density; 3) renal damage and dysfunction when exposed to a Mars roundtrip dose-equivalent of simulated GCR.

Identifiants

pubmed: 38862484
doi: 10.1038/s41467-024-49212-1
pii: 10.1038/s41467-024-49212-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4923

Subventions

Organisme : UK Space Agency (United Kingdom Space Agency)
ID : ST/X000036/1

Informations de copyright

© 2024. The Author(s).

Références

Grigoriev, A. I., Morukov, B. V. & Vorobiev, D. V. Water and electrolyte studies during long-term missions onboard the space stations SALYUT and MIR. Clin. Investig. 72, 169–189 (1994).
pubmed: 8012159 doi: 10.1007/BF00189308
Drummer, C. et al. Water and sodium balances and their relation to body mass changes in microgravity. Eur. J. Clin. Invest. 30, 1066–1075 (2000).
pubmed: 11122321 doi: 10.1046/j.1365-2362.2000.00766.x
Christensen, N. J., Drummer, C. & Norsk, P. Renal and sympathoadrenal responses in space. Am. J. Kidney Dis. 38, 679–683 (2001).
pubmed: 11532706 doi: 10.1053/ajkd.2001.27758
Ingber, D. E. Tensegrity: The Architectural Basis of Cellular Mechanotransduction. Annu. Rev. Physiol. 59, 575–599 (1997).
pubmed: 9074778 doi: 10.1146/annurev.physiol.59.1.575
Goodenow-Messman, D. A., Gokoglu, S. A., Kassemi, M. & Myers, J. G. Numerical characterization of astronaut CaOx renal stone incidence rates to quantify in-flight and post-flight relative risk. Npj Microgravity 8, 1–17 (2022).
doi: 10.1038/s41526-021-00187-z
Pietrzyk, R. A., Jones, J. A., Sams, C. F. & Whitson, P. A. Renal Stone Formation Among Astronauts. Aviat. Space Environ. Med. 78, A9–A13 (2007).
pubmed: 17511294
Gs, A., Pa, W., On, L., LKh, P. & Ct, P. Assessment of the risk factors for urolithiasis in cosmonauts during long flights. Aviakosmicheskaia Ekol. Meditsina Aerosp. Environ. Med. 30, 24–32 (1996).
Whitson Peggy, A., Pietrzyk Robert, A., Pak Charles, Y. C. & Cintron Nitza, M. Alterations in Renal Stone Risk Factors after Space Flight. J. Urol. 150, 803–807 (1993).
doi: 10.1016/S0022-5347(17)35618-5
Whitson, P. A., Pietrzyk, R. A., Morukov, B. V. & Sams, C. F. The Risk of Renal Stone Formation during and after Long Duration Space Flight. Nephron 89, 264–270 (2001).
pubmed: 11598387 doi: 10.1159/000046083
Kassemi, M. & Thompson, D. Prediction of renal crystalline size distributions in space using a PBE analytic model. 1. Effect of microgravity-induced biochemical alterations. Am. J. Physiol. Ren. Physiol. 311, F520–F530 (2016).
doi: 10.1152/ajprenal.00401.2015
Elger, M., Bankir, L. & Kriz, W. Morphometric analysis of kidney hypertrophy in rats after chronic potassium depletion. Am. J. Physiol. Ren. Physiol. 262, F656–F667 (1992).
doi: 10.1152/ajprenal.1992.262.4.F656
Saritas, T. et al. Optical Clearing in the Kidney Reveals Potassium-Mediated Tubule Remodeling. Cell Rep. 25, 2668–2675.e3 (2018).
pubmed: 30517856 pmcid: 6339512 doi: 10.1016/j.celrep.2018.11.021
Yang, G. Y. et al. Renal Atrophy Secondary to Chemoradiotherapy of Abdominal Malignancies. Int. J. Radiat. Oncol. 78, 539–546 (2010).
doi: 10.1016/j.ijrobp.2009.07.1744
Patel, Z. Evidence Report: Risk of Cardiovascular Disease and Other Degenerative Tissue Effects from Radiation Exposure. https://ntrs.nasa.gov/search.jsp?R=20150016006 (2015).
Shimura, T., Kobayashi, J., Komatsu, K. & Kunugita, N. Severe mitochondrial damage associated with low-dose radiation sensitivity in ATM- and NBS1-deficient cells. Cell Cycle 15, 1099–1107 (2016).
pubmed: 26940879 pmcid: 4889229 doi: 10.1080/15384101.2016.1156276
Kim, H.-N. et al. Simulated Galactic Cosmic Rays Modify Mitochondrial Metabolism in Osteoclasts, Increase Osteoclastogenesis and Cause Trabecular Bone Loss in Mice. Int. J. Mol. Sci. 22, 11711 (2021).
pubmed: 34769141 pmcid: 8583929 doi: 10.3390/ijms222111711
Bagnasco, S., Good, D., Balaban, R. & Burg, M. Lactate production in isolated segments of the rat nephron. Am. J. Physiol. Ren. Physiol. 248, F522–F526 (1985).
doi: 10.1152/ajprenal.1985.248.4.F522
Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585–594 (2023).
pubmed: 37468583 pmcid: 10356613 doi: 10.1038/s41586-023-05769-3
Edeani, A. & Cohen, E. P. Radiation Nephropathy. In Onco-Nephrology Curriculum. Ch. 10 (ed. Perazella, M. A.) (American Society of Nephrology, Washington, DC, USA 2016).
Filippi, B. M. et al. MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases. EMBO J. 30, 1730–1741 (2011).
pubmed: 21423148 pmcid: 3101989 doi: 10.1038/emboj.2011.78
Manissorn, J., Khamchun, S., Vinaiphat, A. & Thongboonkerd, V. Alpha-tubulin enhanced renal tubular cell proliferation and tissue repair but reduced cell death and cell-crystal adhesion. Sci. Rep. 6, 28808 (2016).
pubmed: 27363348 pmcid: 4929438 doi: 10.1038/srep28808
Wang, M. et al. Wars2 is a determinant of angiogenesis. Nat. Commun. 7, 12061 (2016).
pubmed: 27389904 pmcid: 4941120 doi: 10.1038/ncomms12061
Jeong, S. J. et al. A threonyl-tRNA synthetase-mediated translation initiation machinery. Nat. Commun. 10, 1357 (2019).
pubmed: 30902983 pmcid: 6430810 doi: 10.1038/s41467-019-09086-0
Ho, D. H. et al. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Cell Biochem. Funct. 36, 431–442 (2018).
pubmed: 30411383 doi: 10.1002/cbf.3364
Ma, C., Kang, H., Liu, Q., Zhu, R. & Cao, Z. Insight into potential toxicity mechanisms of melamine: An in silico study. Toxicology 283, 96–100 (2011).
pubmed: 21376774 doi: 10.1016/j.tox.2011.02.009
Han, X. Lipidomics for studying metabolism. Nat. Rev. Endocrinol. 12, 668–679 (2016).
pubmed: 27469345 doi: 10.1038/nrendo.2016.98
Saudenova, M. et al. Behind every smile there’s teeth: Cathepsin B’s function in health and disease with a kidney view. Biochim. Biophys. Acta BBA—Mol. Cell Res. 1869, 119190 (2022).
doi: 10.1016/j.bbamcr.2021.119190
Grimm, P. R., Coleman, R., Delpire, E. & Welling, P. A. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules. J. Am. Soc. Nephrol. 28, 2597 (2017).
pubmed: 28442491 pmcid: 5576927 doi: 10.1681/ASN.2016090948
Morris, J. H. et al. The scalable precision medicine open knowledge engine (SPOKE): a massive knowledge graph of biomedical information. Bioinformatics 39, btad080 (2023).
pubmed: 36759942 pmcid: 9940622 doi: 10.1093/bioinformatics/btad080
Malkani, S. et al. Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure Development. Cell Rep. 33, 108448 (2020).
pubmed: 33242410 pmcid: 8441986 doi: 10.1016/j.celrep.2020.108448
Ren, H. et al. Spatial organization of the vascular bundle and the interbundle region: three-dimensional reconstruction at the inner stripe of the outer medulla in the mouse kidney. Am. J. Physiol. Ren. Physiol. 306, F321–F326 (2014).
doi: 10.1152/ajprenal.00429.2013
Rodriques, S. G. et al. Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution. Science 363, 1463–1467 (2019).
pubmed: 30923225 pmcid: 6927209 doi: 10.1126/science.aaw1219
Clark, J. Z. et al. Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data. Kidney Int. 95, 787–796 (2019).
pubmed: 30826016 pmcid: 7466803 doi: 10.1016/j.kint.2018.11.028
Ansermet, C. et al. Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetes. Kidney Int. 101, 563–573 (2022).
pubmed: 34838539 doi: 10.1016/j.kint.2021.11.016
Lazareth, H. et al. Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria. Kidney Int. Rep. 6, 1904–1911 (2021).
pubmed: 34307985 pmcid: 8258458 doi: 10.1016/j.ekir.2021.04.004
Chang, F.-C. et al. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PloS One 8, e54668 (2013).
pubmed: 23469160 pmcid: 3585725 doi: 10.1371/journal.pone.0054668
Djudjaj, S. et al. Keratins are novel markers of renal epithelial cell injury. Kidney Int. 89, 792–808 (2016).
pubmed: 26924053 doi: 10.1016/j.kint.2015.10.015
Cohen, E. P. & Robbins, M. E. C. Radiation nephropathy. Semin. Nephrol. 23, 486–499 (2003).
pubmed: 13680538 doi: 10.1016/S0270-9295(03)00093-7
Grimm, P. R. et al. SPAK Isoforms and OSR1 Regulate Sodium-Chloride Co-transporters in a Nephron-specific Manner. J. Biol. Chem. 287, 37673–37690 (2012).
pubmed: 22977235 pmcid: 3488044 doi: 10.1074/jbc.M112.402800
Kaissling, B., Bachmann, S. & Kriz, W. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am. J. Physiol. Ren. Physiol. 248, F374–F381 (1985).
doi: 10.1152/ajprenal.1985.248.3.F374
Liu, J. et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion. JCI Insight 2, e94716 (2017).
pubmed: 28931758 pmcid: 5612583 doi: 10.1172/jci.insight.94716
Terker, A. S. et al. Potassium Modulates Electrolyte Balance and Blood Pressure through Effects on Distal Cell Voltage and Chloride. Cell Metab. 21, 39–50 (2015).
pubmed: 25565204 pmcid: 4332769 doi: 10.1016/j.cmet.2014.12.006
Siddiqui, R., Qaisar, R., Goswami, N., Khan, N. A. & Elmoselhi, A. Effect of Microgravity Environment on Gut Microbiome and Angiogenesis. Life 11, 1008 (2021).
pubmed: 34685381 pmcid: 8541308 doi: 10.3390/life11101008
Stewart, C. S., Duncan, S. H. & Cave, D. R. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol. Lett. 230, 1–7 (2004).
pubmed: 14734158 doi: 10.1016/S0378-1097(03)00864-4
Ticinesi, A. et al. Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not just a Gut-Kidney Axis. A Nutritional Perspective. Nutrients 12, 548 (2020).
pubmed: 32093202 pmcid: 7071363 doi: 10.3390/nu12020548
Klimesova, K., Whittamore, J. M. & Hatch, M. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria. Urolithiasis 43, 107–117 (2015).
pubmed: 25269440 doi: 10.1007/s00240-014-0728-2
Pa, W., Ra, P. & Cf, S. Urine volume and its effects on renal stone risk in astronauts. Aviat. Space Environ. Med. 72, 368–372 (2001).
Whitson, P. A. et al. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight. J. Urol. 182, 2490–2496 (2009).
pubmed: 19765769 doi: 10.1016/j.juro.2009.07.010
Zerwekh, J. E., Odvina, C. V., Wuermser, L.-A. & Pak, C. Y. C. Reduction of Renal Stone Risk by Potassium-Magnesium Citrate During 5 Weeks of Bed Rest. J. Urol. 177, 2179–2184 (2007).
pubmed: 17509313 doi: 10.1016/j.juro.2007.01.156
Jones, J. A., Johnston, S., Campbell, M., Miles, B. & Billica, R. Endoscopic surgery and telemedicine in microgravity: developing contingency procedures for exploratory class spaceflight. Urology 53, 892–897 (1999).
pubmed: 10223479 doi: 10.1016/S0090-4295(99)00024-2
Simon, J. C., Dunmire, B., Bailey, M. R. & Sorensen, M. D. Developing Complete Ultrasonic Management of Kidney Stones for Spaceflight. J. Space Saf. Eng. 3, 50–57 (2016).
pubmed: 29034360 doi: 10.1016/S2468-8967(16)30018-0
Okada, A. et al. Bisphosphonate Use May Reduce the Risk of Urolithiasis in Astronauts on Long-Term Spaceflights. JBMR 6, e10550 (2022).
Nijenhuis, T. et al. Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int. 64, 555–564 (2003).
pubmed: 12846750 doi: 10.1046/j.1523-1755.2003.00128.x
Nijenhuis, T. et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J. Clin. Invest. 115, 1651–1658 (2005).
pubmed: 15902302 pmcid: 1090474 doi: 10.1172/JCI24134
Bolland, M. J. et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos. Int. 18, 479–486 (2007).
pubmed: 17120180 doi: 10.1007/s00198-006-0259-y
Ostroverkhova, D. S. et al. Calcium-Sensing Receptor and Regulation of WNK Kinases in the Kidney. Cells 9, 1644 (2020).
pubmed: 32659887 pmcid: 7407487 doi: 10.3390/cells9071644
Cipriani, C., Nemeth, E. F. & Bilezikian, J. P. Chapter 71—Drugs acting on the calcium receptor: Calcimimetics and calcilytics. In Principles of Bone Biology (Fourth Edition) (eds Bilezikian, J. P., Martin, T. J., Clemens, T. L. & Rosen, C. J.) 1657–1670 (Academic Press). https://doi.org/10.1016/B978-0-12-814841-9.00071-3 (2020).
Ware, J. S. et al. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. J. Clin. Invest. 127, 3367–3374 (2017).
pubmed: 28783044 pmcid: 5669583 doi: 10.1172/JCI89812
Rodríguez-Soriano, J., Vallo, A. & Aguirre, M. Bone mineral density and bone turnover in patients with Bartter syndrome. Pediatr. Nephrol. 20, 1120–1125 (2005).
pubmed: 15942790 doi: 10.1007/s00467-005-1901-1
Rejnmark, L., Vestergaard, P., Heickendorff, L., Andreasen, F. & Mosekilde, L. Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results From a Randomized Controlled Study With Bumetanide. J. Bone Miner. Res. 21, 163–170 (2006).
pubmed: 16355285 doi: 10.1359/JBMR.051003
Hughson, R. L. et al. Increased postflight carotid artery stiffness and inflight insulin resistance resulting from 6-mo spaceflight in male and female astronauts. Am. J. Physiol. -Heart Circ. Physiol. 310, H628–H638 (2016).
pubmed: 26747504 doi: 10.1152/ajpheart.00802.2015
Georgianos, P. I., Sarafidis, P. A. & Liakopoulos, V. Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression? Am. J. Hypertens. 28, 958–965 (2015).
pubmed: 25687879 doi: 10.1093/ajh/hpv004
Inserra, F., Forcada, P., Castellaro, A. & Castellaro, C. Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path. Front. Med. 8, 765924 (2021).
doi: 10.3389/fmed.2021.765924
Norsk, P., Asmar, A., Damgaard, M. & Christensen, N. J. Fluid shifts, vasodilatation and ambulatory blood pressure reduction during long duration spaceflight. J. Physiol. 593, 573–584 (2015).
pubmed: 25774397 pmcid: 4324706 doi: 10.1113/jphysiol.2014.284869
Berg, S. et al. ilastik: interactive machine learning for (bio)image analysis. Nat. Methods 16, 1226–1232 (2019).
pubmed: 31570887 doi: 10.1038/s41592-019-0582-9
Park, Y.-G. et al. Protection of tissue physicochemical properties using polyfunctional crosslinkers. Nat. Biotechnol. 37, 73–83 (2019).
doi: 10.1038/nbt.4281
Voigt, F. F. et al. The mesoSPIM initiative: open-source light-sheet microscopes for imaging cleared tissue. Nat. Methods 16, 1105–1108 (2019).
pubmed: 31527839 pmcid: 6824906 doi: 10.1038/s41592-019-0554-0
Pidhorskyi, S., Morehead, M., Jones, Q., Spirou, G. & Doretto, G. syGlass: Interactive Exploration of Multidimensional Images Using Virtual Reality Head-mounted Displays. Preprint at https://doi.org/10.48550/arXiv.1804.08197 (2018).
Imaris Microscopy Image Analysis Software | Comparison—Imaris. Oxford Instruments https://imaris.oxinst.com/packages .
Shimizu, R. et al. Nrf2 alleviates spaceflight-induced immunosuppression and thrombotic microangiopathy in mice. Commun. Biol. 6, 875 (2023).
pubmed: 37626149 pmcid: 10457343 doi: 10.1038/s42003-023-05251-w
Suzuki, N. et al. Gene expression changes related to bone mineralization, blood pressure and lipid metabolism in mouse kidneys after space travel. Kidney Int. 101, 92–105 (2022).
pubmed: 34767829 doi: 10.1016/j.kint.2021.09.031

Auteurs

Keith Siew (K)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK. k.siew@ucl.ac.uk.

Kevin A Nestler (KA)

The Institute for Biomedical Sciences (IBS), The George Washington University, Washington, DC, USA.

Charlotte Nelson (C)

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.

Viola D'Ambrosio (V)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK.
Department of Experimental and Translational Medicine, Università Cattolica del Sacro Cuore di Roma, Rome, Italy.

Chutong Zhong (C)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK.

Zhongwang Li (Z)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK.
Centre for Advanced Biomedical Imaging, University College London, London, UK.
Centre for Computational Medicine, University College London, London, UK.

Alessandra Grillo (A)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK.

Elizabeth R Wan (ER)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK.

Vaksha Patel (V)

Department of Renal Medicine, University College London, London, UK.

Eliah Overbey (E)

Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.

JangKeun Kim (J)

Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.

Sanghee Yun (S)

University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Michael B Vaughan (MB)

School of Medicine, College of Medicine and Health, University College Cork, Cork, Ireland.
Tissue Engineering and Biomaterials Group, Ghent University, Ghent, Belgium.
Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Chris Cheshire (C)

Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.

Laura Cubitt (L)

Applied Biotechnology Laboratory, The Francis Crick Institute, London, UK.

Jessica Broni-Tabi (J)

Sainsbury Wellcome Centre for Neural Circuits and Behaviour, University College London, London, UK.

Maneera Yousef Al-Jaber (MY)

Anti-Doping Laboratory Qatar, Doha, Qatar.

Valery Boyko (V)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Cem Meydan (C)

Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.

Peter Barker (P)

MRC MDU Mouse Biochemistry Laboratory, University of Cambridge, Cambridge, UK.

Shehbeel Arif (S)

Center for Data Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Fatemeh Afsari (F)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Noah Allen (N)

Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.

Mohammed Al-Maadheed (M)

Anti-Doping Laboratory Qatar, Doha, Qatar.
Centre of Metabolism and Inflammation, University College London, London, UK.

Selin Altinok (S)

School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Nourdine Bah (N)

Applied Biotechnology Laboratory, The Francis Crick Institute, London, UK.

Samuel Border (S)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Amanda L Brown (AL)

Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Keith Burling (K)

MRC MDU Mouse Biochemistry Laboratory, University of Cambridge, Cambridge, UK.

Margareth Cheng-Campbell (M)

Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.
Blue Marble Space Institute of Science, Seattle, WA, USA.

Lorianna M Colón (LM)

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.

Lovorka Degoricija (L)

KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Nichola Figg (N)

Department of Medicine, University of Cambridge, Cambridge, UK.

Rebecca Finch (R)

School of Health, Science and Wellbeing, Staffordshire University, Stoke-on-Trent, UK.

Jonathan Foox (J)

Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.
The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.

Pouya Faridi (P)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Alison French (A)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Samrawit Gebre (S)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Peter Gordon (P)

Sainsbury Wellcome Centre for Neural Circuits and Behaviour, University College London, London, UK.

Nadia Houerbi (N)

Physiology, Biophysics & Systems Biology, Weill Cornell Medical College, New York, NY, USA.

Hossein Valipour Kahrood (H)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Monash Bioinformatics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Frederico C Kiffer (FC)

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Aleksandra S Klosinska (AS)

Division of Experimental Medicine & Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, UK.

Angela Kubik (A)

Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.

Han-Chung Lee (HC)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Yinghui Li (Y)

State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China.

Nicholas Lucarelli (N)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Anthony L Marullo (AL)

School of Medicine, College of Medicine and Health, University College Cork, Cork, Ireland.

Irina Matei (I)

Cornell Center for Immunology, Cornell University, Ithaca, NY, USA.
Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.

Colleen M McCann (CM)

Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Sayat Mimar (S)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Ahmed Naglah (A)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Jérôme Nicod (J)

Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Kevin M O'Shaughnessy (KM)

Division of Experimental Medicine & Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, UK.

Lorraine Christine De Oliveira (LC)

Blue Marble Space Institute of Science, Seattle, WA, USA.
Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

Leah Oswalt (L)

Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Laura Ioana Patras (LI)

Pediatrics, Weill Cornell Medical College, New York, NY, USA.

San-Huei Lai Polo (SH)

KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

María Rodríguez-Lopez (M)

Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Candice Roufosse (C)

Department of Immunology and Inflammation, Imperial College London, London, UK.

Omid Sadeghi-Alavijeh (O)

Department of Renal Medicine, University College London, London, UK.

Rebekah Sanchez-Hodge (R)

Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Anindya S Paul (AS)

Department of Medicine-Nephrology & Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.

Ralf Bernd Schittenhelm (RB)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Annalise Schweickart (A)

Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, NY, USA.

Ryan T Scott (RT)

KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Terry Chin Choy Lim Kam Sian (TC)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Willian A da Silveira (WA)

School of Health, Science and Wellbeing, Staffordshire University, Stoke-on-Trent, UK.
International Space University, 67400, Illkirch-Graffenstaden, France.

Hubert Slawinski (H)

Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Daniel Snell (D)

Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Julio Sosa (J)

University Health Network, Toronto, ON, Canada.

Amanda M Saravia-Butler (AM)

KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Marshall Tabetah (M)

Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN, USA.

Erwin Tanuwidjaya (E)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Simon Walker-Samuel (S)

Centre for Advanced Biomedical Imaging, University College London, London, UK.
Centre for Computational Medicine, University College London, London, UK.

Xiaoping Yang (X)

Proteomics, King's College London, London, UK.
Division of Experimental Medicine & Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, UK.

Haijian Zhang (H)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Jasminka Godovac-Zimmermann (J)

Department of Renal Medicine, University College London, London, UK.

Pinaki Sarder (P)

Department of Medicine-Quantitative Health Section, University of Florida, Gainesville, FL, USA.
Departments of Biomedical Engineering and Electrical and Computer Engineering, University of Florida, Gainesville, FL, USA.

Lauren M Sanders (LM)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.
Blue Marble Space Institute of Science, Seattle, WA, USA.

Sylvain V Costes (SV)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Robert A A Campbell (RAA)

Sainsbury Wellcome Centre for Neural Circuits and Behaviour, University College London, London, UK.

Fathi Karouia (F)

Blue Marble Space Institute of Science, Seattle, WA, USA.
Space Research Within Reach, San Francisco, CA, USA.
Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA.

Vidya Mohamed-Alis (V)

Anti-Doping Laboratory Qatar, Doha, Qatar.
Centre of Metabolism and Inflammation, University College London, London, UK.

Samuel Rodriques (S)

Applied Biotechnology Laboratory, The Francis Crick Institute, London, UK.

Steven Lynham (S)

Proteomics, King's College London, London, UK.

Joel Ricky Steele (JR)

Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Sergio Baranzini (S)

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.

Hossein Fazelinia (H)

Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.

Zhongquan Dai (Z)

State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China.

Akira Uruno (A)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.

Dai Shiba (D)

Mouse Epigenetics Project, ISS/Kibo experiment, Japan Aerospace Exploration Agency (JAXA), Tsukuba, Ibaraki, Japan.
JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency (JAXA), Tsukuba, Ibaraki, Japan.

Masayuki Yamamoto (M)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Department of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan.

Eduardo A C Almeida (E)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Elizabeth Blaber (E)

Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.
Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, USA.
Stanley Center for Psychiatric Research, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.

Jonathan C Schisler (JC)

Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Amelia J Eisch (AJ)

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Masafumi Muratani (M)

Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Sara R Zwart (SR)

Department of Preventative Medicine and Community Health, University of Texas Medical Branch, Galveston, TX, USA.

Scott M Smith (SM)

NASA Johnson Space Center, Houston, TX, USA.

Jonathan M Galazka (JM)

Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.

Christopher E Mason (CE)

Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.
The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medical College, New York, NY, USA.
The Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, USA.

Afshin Beheshti (A)

KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.
Broad Institute, Cambridge, MA, USA.
Space Biosciences Division, Universities Space Research Association (USRA), Washington, DC, USA.

Stephen B Walsh (SB)

London Tubular Centre, Department of Renal Medicine, University College London, London, UK. stephen.walsh@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH